Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2022-09-02 00:00:00 ET · period of report 2022-09-01 · accession 0001334549-22-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-02 | 2022-09-01 | LSTA | Mazzo David J | CEO, Dir | A - Grant | $0.5 | +150.0K | 809.2K | +23% | +$75.0K | |
| 2022-09-02 | 2022-09-01 | LSTA | Mazzo David J | CEO, Dir | F - Tax | $0.5 | -69.7K | 739.4K | -9% | -$34.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-01 | A | A | 150,000 | $0.5 | 809,186 | D | — | — | (F1) Reflects 150,000 in performance rights, the criteria for which was satisfied on September 1, 2022 and which vested on that same date. (F2) Includes 371,750 of unvested restricted stock. |
| 2 | Common | Common Stock | 2022-09-01 | F | D | 69,742 | $0.5 | 739,444 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of performance rights. (F2) Includes 371,750 of unvested restricted stock. |